Everlight USA, Inc. v. Takeda Pharmaceuticals International, Inc.
Filing
5
ORDER granting Respondent's 4 Unopposed Motion for Extension of Time to File Response/Reply 2 Petitioner's Amended Motion to Quash Deposition Subpoena and Motion for Protective Order ( Responses due by 5/24/2024 ); denying as moot 1 Petitioner's Motion to Quash Deposition Subpoena and Motion for Protective Order ( Document No. 1). Signed by US Magistrate Judge David Keesler on 4/25/24. (mga)
IN THE UNITED STATES DISTRICT COURT
FOR THE WESTERN DISTRICT OF NORTH CAROLINA
CHARLOTTE DIVISION
CASE NO. 3:24-MC-047-FDW-DCK
EVERLIGHT USA, INC.,
Petitioner,
v.
TAKEDA PHARMACEUTICALS
COMPANY LIMITED, and TAKEDA
PHARMACEUTICALS U.S.A, INC.,
Respondent.
)
)
)
)
)
)
)
)
)
)
)
)
ORDER
THIS MATTER IS BEFORE THE COURT on Respondents’ “…Unopposed Motion
For An Extension Of Time To Respond” (Document No. 4) filed April 25, 2024. This motion has
been referred to the undersigned Magistrate Judge pursuant to 28 U.S.C. § 636(b), and immediate
review is appropriate.
Having carefully considered the motion and the record, and noting Petitioner’s consent, the
undersigned will grant the motion. Further extensions are unlikely to be allowed.
IT IS, THEREFORE, ORDERED that Respondents’ “…Unopposed Motion For An
Extension Of Time To Respond” (Document No. 4) is GRANTED with modification.
Respondents shall file a response to “Petitioner’s Amended Motion To Quash Deposition
Subpoena And Motion For Protective Order” (Document No. 2) on or before May 24, 2024.
IT IS FURTHER ORDERED that “Petitioner’s Motion To Quash Deposition Subpoena
And Motion For Protective Order” (Document No. 1) is DENIED AS MOOT.
SO ORDERED.
Signed: April 25, 2024
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?